Department of Cardiology and Angiology, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
Coron Artery Dis. 2022 Sep 1;33(6):485-489. doi: 10.1097/MCA.0000000000001157. Epub 2022 Jul 11.
Multivessel coronary disease is a frequent finding in patients with STEMI. However, choosing the optimal treatment strategy for these patients can be challenging. The benefit of complete versus culprit-vessel-only revascularization demonstrated by several studies led to a change in the current 2018 ESC/EACTS revascularization guidelines recommending treatment of nonculprit lesions before hospital discharge. This article summarizes current data in this area, looks at remaining knowledge gaps and gives an outlook regarding ongoing trials. The latter will provide further robust evidence for the optimal management of patients with STEMI and multivessel disease.
多支冠状动脉疾病在 STEMI 患者中较为常见。然而，为这些患者选择最佳的治疗策略可能具有挑战性。几项研究表明，完全血运重建与罪犯血管血运重建相比具有优势，这导致了当前 2018 年 ESC/EACTS 血运重建指南的改变，建议在出院前治疗非罪犯病变。本文总结了该领域的现有数据，探讨了尚存的知识空白，并对正在进行的试验进行了展望。这些试验将为 STEMI 合并多支血管疾病患者的最佳治疗提供更有力的证据。
